GlassScriptPhysician profile
Leonne Moient Deravine
NPI 1245678119
$4,271.14
in general payments reported to CMS, 2019-2025
15 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $911 · 2022: $713 · 2023: $1,760 · 2024: $755 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $781.32 | 2023-2025 | Ingrezza |
| Acadia Pharmaceuticals INC | $648.92 | 2021-2024 | Nuplazid |
| Ucb, INC. | $629.95 | 2021-2024 | Briviact, Nayzilam |
| Otsuka America Pharmaceutical, INC. | $426.62 | 2023-2024 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $335.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $285.22 | 2021-2022 | |
| Neurelis, INC. | $273.74 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $240.94 | 2023-2024 | Austedo Xr, Uzedy |
| Smith+Nephew, INC. | $200.07 | 2021-2024 | Pico 14, Renasys Touch, Pico |
| Sk Life Science, INC. | $118.92 | 2023 | Xcopri |
| Sumitomo Pharma America, INC. | $118.46 | 2023 | Aptiom, Gemtesa |
| Jazz Pharmaceuticals INC. | $108.91 | 2022 | |
| Sunovion Pharmaceuticals INC. | $60.83 | 2021 | |
| Vivus LLC | $24.13 | 2023 | Qsymia |
| Astellas Pharma US INC | $17.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonne Deravine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.